← Browse by Condition
Medical Condition

preeclampsia

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 4, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for preeclampsia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — preeclampsia Clinical Trials

How many clinical trials are currently recruiting for preeclampsia?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for preeclampsia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for preeclampsia?
preeclampsia research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a preeclampsia clinical trial?
Eligibility criteria for preeclampsia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Phase 4
1
Top Sponsors
Alexandra Hospital, Athens, Greece 1 trial
University Hospital, Antwerp 1 trial
Mayo Clinic 1 trial
Herlev Hospital 1 trial
University of Colorado, Denver 1 trial

Recruiting Clinical Trials

NCT07361679 Phase 4
Recruiting
LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
Enrollment
100 pts
Location
Greece
Sponsor
Alexandra Hospital, Athens, Gr...
View Trial →
NCT07084727
Recruiting
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
Enrollment
60 pts
Location
Belgium
Sponsor
University Hospital, Antwerp
View Trial →
NCT06333652 Phase 2
Recruiting
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Enrollment
14 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06844019
Recruiting
Birth & Breastfeeding Support Study
Enrollment
1,628 pts
Location
Denmark
Sponsor
Herlev Hospital
View Trial →
NCT02391519
Recruiting
Effects of High Altitude on AMPK Activation
Enrollment
84 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05999851
Recruiting
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
Enrollment
400 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT05287321 Phase 3
Recruiting
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
Enrollment
58 pts
Location
South Korea
Sponsor
Yoo-min Kim
View Trial →

Related Conditions

preeclampsia severe (1) toxemia of pregnancy (1) pregnancy complications (1) hypertension pregnancy induced (1) gestational hypertension (1) endothelial function fmd (1) retinal vessels (1) breastfeeding (1) breastfeeding initiation (1) breastfeeding duration (1) birth (1) birth practices (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology